---
{"dg-publish":true,"permalink":"/USMLE/MSK/Fibromyalgia/"}
---

# Epidemiology
---
- <span style="background:rgba(240, 200, 0, 0.2)">Most common in females 20–50 years old.</span>

# Etiology
---


# Pathophysiology
---
Pervasive symptoms despite the absence of identifiable inflammation or structural changes on physical exam, imaging, or histology.

# Clinical features
---
- <span style="background:rgba(240, 200, 0, 0.2)">Widespread musculoskeletal pain</span>
- <span style="background:rgba(240, 200, 0, 0.2)">Morning stiffness (Typically lasts &lt; 60 minutes)</span>
- Fatigue
- <span style="background:rgba(240, 200, 0, 0.2)">Impaired attention & concentration</span>
- <span style="background:rgba(240, 200, 0, 0.2)">Psychiatric disturbances (eg, depression, anxiety)</span>
- Symptoms lasting for ≥ 3 months
- Physical examination
	- Multiple tender points at characteristic locations
	- <span style="background:rgba(240, 200, 0, 0.2)">Absence of joint or muscle inflammation</span>
# Diagnostics
---
<span style="background:rgba(240, 200, 0, 0.2)">Normal [[USMLE/Pathology/Acute phase reactants\|acute phase reactants]] (eg, ESR, CRP) & other inflammatory markers</span>

# Treatment
---
- Progressive exercise regimen
- Medications: tricyclic [[USMLE/Psychiatry/Antidepressants\|antidepressants]], cyclic skeletal muscle relaxants, serotonin-norepinephrine reuptake inhibitors

